Clinical pharmacists actively participated in the glucose-lowering therapy for three type 2 diabetes patients with obesity and hepatic insufficiency to explore the role of clinical pharmacists in clinical treatment. Through the participation in the formulation of drug treatment by clinical pharmacists, GLP-1 preparation was used for hypoglycemic treatment, and the effect was promising. There was no significant change in the patients' liver function. By actively participating in the formulation of glucose-lowering therapy, clini-cal pharmacists can improve the effectiveness and safety of drug treatment.

Objective: To explore the association between long-term changes in blood pressure (BP) levels and the incidence of cardiovascular diseases (CVD). Methods: A total of 5 752 participants, who participated baseline examination in 1992-1993 and re-examination in 2007, were followed up till December 31, 2013 according to the study protocol of the Chinese Multi-provincial Cohort Study. Participants were stratified by baseline BP and re-examination BP and cross-combined into 9 subgroups. The 20-year incidence of acute cardiovascular events, acute coronary heart disease (CHD) and acute stroke events were analyzed and association between disease incidence and 15-year changes in BP were determined using the competing risk regression model. Results: (1) There were 523 CVD events (170 CHD, 373 stroke) during the 20 years follow up. The number of participants with baseline systolic blood pressure (SBP)/diastolic blood pressure (DBP) of <130/80 mmHg (1 mmHg=0.133 kPa), 130-139/80-89 mmHg, and hypertension were 2 892 (50.3%), 1 328 (23.1%) and 1 532 (26.6%), respectively. (2) Among participants with baseline SBP of 130-139 mmHg or DBP of 80-89 mmHg, 870 (65.5%) progressed to hypertension and 279 (21.0%) maintained at the same stratum over a 15-year follow up period. (3) After adjustment for age, sex, body mass index, smoking status, diabetes, total cholesterol, and high-density lipoprotein cholesterol at baseline, participants maintained SBP/DBP at 130-139/80-89 mmHg had a higher risk of developing acute cardiovascular events, CHD and stroke with the hazard ratios (HR) and 95% confidence interval (95%CI) of 2.04 (1.16, 3.57), 3.29 (1.30, 8.35) and 1.63 (0.80, 3.33), compared with those who maintained their SBP < 130 mmHg and DBP <80 mmHg. Participants whose BP increased from 130-139/80-89 mmHg to hypertension over the follow up period had 2.81-fold (1.84, 4.29), 3.17-fold (1.43, 7.03) and 2.71-fold (1.65, 4.44) higher risk for the incidence of acute cardiovascular events, CHD, and stroke, respectively, compared with participants who maintained their SBP <130 mmHg and DBP <80 mmHg. Conclusions Participants with SBP/DBP of 130-139/80-89 mmHg have a high long-term risk for progression to hypertension. Sustained exposure to SBP/DBP of 130-139/80-89 mmHg or higher increases the risk of CVD incidence, and our results highlight the importance of early prevention for participants with this BP stratum.

Objective:To explore the chain mediating effect of subjective well-being and coping style between disease cognition and self care in elderly patients with major depression. To provide suggestions for establishing nursing plans for elderly patients with major depression.Methods:This was a cross-sectional study. Two hundred and fourteen elderly patients with major depression admitted to the Department of Psychiatry of the General Hospital of the Northern Theater Command of the People ′s Liberation Army of China between February 2020 and December 2021 were selected as study subjects by convenience sampling. The patients were tested with Self-rating Depression Scale, the Brief Illness Perception Questionnaire, Appraisal of Self-care Agency Scale-revised, General Well-being, and Trait Coping Style Questionnaire. Correlation tests were performed with Pearson's correlation analysis; the median effect test was performed with the bias-corrected percentile Bootstrap method. Results:Disease cognition scores were negatively correlated with subjective well-being, positive coping, and self care scores ( r=-0.25, -0.34, -0.51, all P<0.05), but positively correlated with negative coping scores ( r=0.28, P<0.05). Disease cognition had a significant direct predictive effect on self care ( β=-0.12, P<0.05); disease cognition directly predicted subjective well-being, positive coping and negative coping ( β=-0.42, -0.15, 0.16, all P<0.05); subjective well-being directly predicted positive coping, negative coping and self care ( β=0.23, -0.19, 0.26, all P<0.05); positive coping and negative coping directly predicted self care ( β=0.40, -0.32, both P<0.05). The mediating effect value of subjective well-being accounted for 33.12% of the total effect. The mediating effect of positive coping accounted for 14.09% of the total effect. The mediating effect of negative coping accounted for 13.35% of the total effect. The mediating effect between subjective well-being and positive coping accounted for 10.12% of the total effect.The mediating effect between subjective well-being and negative coping accounted for 8.37% of the total effect. Conclusions:The disease cognition of elderly patients with major depression can not only directly affect self-care, but also indirectly affect self care through the mediating effect of subjective well-being, coping style, and the chain mediating effect of subjective well-being→coping style.

The pathogenesis of bipolar disorder(BD)is unknown,and objective biomarkers with clinical guidance are lacking.Extracellular vesicles(EV)are lipid bilayer-enclosed vesicles that carry cargo from originating cells,influencing the processes of recipient cells.They are capable of crossing the blood-brain barrier and reflecting the ongoing processes in the central nervous system.Compelling data indicates that EV could mediate BD pathophysiological processes such as neurocognitive impairment,neuroinflammatory diffusion,and metabolic dysfunction.Therefore,EV has the potential to become a reliable biomarker and therapy for BD,providing new ideas for revealing the pathogenesis and clinical diagnosis and treatment of BD.

The TEA domain (TEAD) family proteins (TEAD1‒4) are essential transcription factors that control cell differentiation and organ size in the Hippo pathway. Although the sequences and structures of TEAD family proteins are highly conserved, each TEAD isoform has unique physiological and pathological functions. Therefore, the development and discovery of subtype selective inhibitors for TEAD protein will provide important chemical probes for the TEAD-related function studies in development and diseases. Here, we identified a novel TEAD1/3 covalent inhibitor (DC-TEADin1072) with biochemical IC